Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome
Relation of Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome in Couples With Male Infertility
1 other identifier
observational
120
1 country
1
Brief Summary
In the current era of assisted reproductive techniques where technology can help overcome defects in sperm function, the value of semen analysis has become even more inaccurate. Initial reports of intracytoplasmic sperm injection revealed its ability to bypass the natural selection process and enable men with severely impaired semen parameters to achieve both clinical pregnancy and live birth
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2017
CompletedFirst Posted
Study publicly available on registry
April 26, 2017
CompletedStudy Start
First participant enrolled
April 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2019
CompletedMay 28, 2020
May 1, 2020
1.5 years
April 23, 2017
May 26, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
clinical pregnancy rate
4 weeks
Interventions
flowcytometric test where sperm DNA breaks are evaluated indirectly through the DNA denaturability. The assay measures the susceptibility of sperm DNA to acid-induced DNA denaturation in situ, followed by staining with the fluorescence dye acridine orange. By using a flow cytometer 5.000-10.000 sperm can be analyzed within few seconds and thus provide a less subjective result compared to the World health organization analysis where only 1-300 cells are analyzed.
Eligibility Criteria
The study will include all infertile couples undergoing intracytoplasmic sperm injection in The Department of Dermatology and Andrology with assisted reproductive unit at women's health hospital, Assiut University Hospital.
You may qualify if:
- Infertile male patients with abnormal semen parameters.
- Normal female partner aged \<38 years.
You may not qualify if:
- Female patients with obvious infertility factor.
- Male patients with azoospermia.
- Male patients with systemic diseases.
- Male patients receiving cytotoxic therapy.
- Male patients with genital pathology as cryptorchidism.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ahmed Abbas
Assiut, Cairo Governorate, 002, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
April 23, 2017
First Posted
April 26, 2017
Study Start
April 1, 2018
Primary Completion
September 15, 2019
Study Completion
October 30, 2019
Last Updated
May 28, 2020
Record last verified: 2020-05